2 FTSE 100 shares I’d buy in July

Here, this Fool explains why he’s adding these two FTSE 100 shares to his portfolio, both for July and the years to come.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Shot of an young Indian businesswoman sitting alone in the office at night and using a digital tablet

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

2022 has proved to be a volatile time for the UK stock market. With a Covid-19 hangover in full swing, and macroeconomic pressures such as inflation, year-to-date the FTSE 100 has fallen by nearly 4%.

With this drop, I’m on the lookout for FTSE 100 shares I can add to my portfolio in July and hold for years to come. Here are two I’d buy today.

Unilever

My first pick would be FTSE 100 powerhouse Unilever (LSE: ULVR). The company owns over 400 household brands, including names such as Ben & Jerry’s, Persil, and Sure. In 2022, the stock is down 5%.

Should you invest £1,000 in Unilever right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Unilever made the list?

See the 6 stocks

Created with Highcharts 11.4.3Unilever PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

What I most like about Unilever is its strong brand recognition. With a third of the world using its products daily, this gives the firm, to an extent, more pricing power. While the cost of living is increasing, it’s less likely that consumers will cut back on the essential items that the business sells. Chief executive Alan Jope warned earlier in the year of inflationary concerns. However, with a portfolio of well-known brands, I think the firm could fare well against the threat of surging rates.

In its latest results, Unilever also highlighted the start of a €3bn two-year buyback scheme. It began the first €750m instalment of this back in March. And this should hopefully boost the FTSE 100 share’s price in times to come.

My biggest concern with Unilever is its debt, which currently sits at over €25bn. With interest rates rising, this may also make the debt more difficult to eradicate. This could hold the firm back in the future.

However, I still have faith in Unilever. Its strong brand presence and stable nature are key for me in these volatile times. As such, I’d happily add the stock to my portfolio today.

GlaxoSmithKline

My second FTSE 100 buy would be pharmaceutical giant GlaxoSmithKline (LSE: GSK). It’s a healthcare business that offers medicines and vaccines globally.

GSK is similar to Unilever in the steadiness it can offer during stock market woes. And the fact that its share price is up 12% in the first half of 2022 is evidence of this. Healthcare and medicines are a requirement regardless of the economy. This has only been highlighted by the pandemic.

Created with Highcharts 11.4.3GSK PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

The company also posted some strong results in its latest update. The first quarter saw its sales increase by 32% to £9.8bn. Within this, its biopharma division saw a 40% rise in sales, while its consumer healthcare unit saw a 14% growth.

These impressive results posted by Glaxo may be threatened in the months ahead by headwinds such as supply chain issues and rising costs.

Yet despite this, I would buy GSK today. With economic conditions set to potentially worsen, the pharmaceuticals firm is a useful addition to my portfolio. Its 4.2% dividend yield may also offer me some form of protection against rising inflation in the months ahead.

Should you buy Unilever now?

Don’t make any big decisions yet.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — has revealed 5 Shares for the Future of Energy.

And he believes they could bring spectacular returns over the next decade.

Since the war in Ukraine, nations everywhere are scrambling for energy independence, he says. Meanwhile, they’re hellbent on achieving net zero emissions. No guarantees, but history shows...

When such enormous changes hit a big industry, informed investors can potentially get rich.

So, with his new report, Mark’s aiming to put more investors in this enviable position.

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Charlie Keough has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Can this FTSE 250 underperformer turn things around in 2025?

After underperforming since its IPO, shares in Dr Martens have finally started to show some life. Is 2025 the year…

Read more »

Investing Articles

Here’s what £20,000 invested in Rolls-Royce shares at the start of 2024 is worth today

2024 was another brilliant year for Rolls-Royce shares, which almost doubled investors' money. Harvey Jones now wonders if the excitement…

Read more »

Investing Articles

Ahead of its merger with Three, is Vodafone’s share price worth a punt?

The Vodafone share price continues to fall despite the firm’s deal to merge with Three being approved. Could this be…

Read more »

Dividend Shares

3 simple passive income investment ideas to consider for 2025

It’s never been easier to generate passive income from the stock market. Here are three straightforward investment strategies to consider…

Read more »

Investing Articles

I was wrong about the IAG share price last year. Should I buy it in 2025?

The IAG share price soared in 2024 and analysts are expecting more of the same in 2025. So should Stephen…

Read more »

Investing Articles

Here’s the dividend forecast for National Grid shares through to 2027

After a volatile 12 months, National Grid shares are expected to provide a dividend yield of 4.8% for the company’s…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Growth Shares

2 exceptional growth funds that beat Scottish Mortgage shares in 2024

Scottish Mortgage shares generated double-digit returns for investors in 2024. But these two growth-focused investment funds did much better.

Read more »

Investing Articles

If a 40-year-old put £500 a month in S&P 500 shares, here’s what they could have by retirement

A regular investment in S&P 500 shares could help a middle-aged person build a million-pound portfolio. Royston Wild explains.

Read more »